Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole
- 1 December 1991
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 36 (12) , 1665-1669
- https://doi.org/10.1007/bf01296606
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Stereoselective Interaction of Omeprazole with Warfarin in Healthy MenTherapeutic Drug Monitoring, 1989
- Drugs other than H2-receptor antagonists as clinically important inhibitors of drug metabolism in vivoPharmacology & Therapeutics, 1987
- Oral phenytoin pharmacokinetics during omeprazole therapy.British Journal of Clinical Pharmacology, 1987
- Propranolol steady-state pharmacokinetics are unaltered by omeprazoleEuropean Journal of Clinical Pharmacology, 1987
- Famotidine: A Notable Lack of Drug InteractionsScandinavian Journal of Gastroenterology, 1987
- Inhibition of human liver cytochrome P‐450 by omeprazole.British Journal of Clinical Pharmacology, 1986
- HOW POTENT IS THE INHIBITION OF DRUG METABOLISM BY OMEPRAZOLE?The Lancet, 1984
- Omeprazole: effects on oxidative drug metabolism.British Journal of Clinical Pharmacology, 1984
- INHIBITION OF DRUG METABOLISM BY OMEPRAZOLEThe Lancet, 1984
- Interactions and Non-Interactions with RanitidineClinical Pharmacokinetics, 1984